Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African

Stanford E Mwasongwe1, Bessie Young2,3, Aurelian Bidulescu4

  • 1Jackson Heart Study, Jackson State University, 350 W. Woodrow Wilson Ave., Suite 701, Jackson, MS, 39213, USA. smwasongwe@umc.edu.

BMC Nephrology
|September 22, 2018
PubMed

Insights

A multi-marker panel showed moderate predictive improvement for kidney disease risk in African Americans. This panel, including biomarkers like adiponectin and hsCRP, aids in predicting chronic kidney disease (CKD) and rapid kidney function decline (RKFD).

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Biomarker Discovery

Background:

  • Limited research exists on using multiple biomarkers for predicting renal outcomes in African Americans.
  • This study investigates the utility of a multi-marker panel in assessing kidney disease risk within this population.

Purpose of the Study:

  • To evaluate the incremental usefulness of a multi-marker panel for predicting incident chronic kidney disease (CKD) and rapid kidney function decline (RKFD).
  • To identify specific biomarkers that contribute to predicting renal outcomes in African Americans.

Main Methods:

  • The Jackson Heart Study cohort, comprising 2813 participants without prevalent CKD, was analyzed.
  • Nine biomarkers (adiponectin, aldosterone, BNP, cortisol, hsCRP, endothelin, homocysteine, plasma renin activity and mass) were measured.
  • Multiple logistic regression and backward elimination were used to model associations between biomarkers and renal outcomes (CKD and RKFD).

Main Results:

  • The multi-marker panel significantly predicted both incident CKD and RKFD.
  • Plasma adiponectin and leptin were associated with incident CKD, while adiponectin, hsCRP, and aldosterone were linked to RKFD.
  • Biomarkers demonstrated a moderate improvement in predicting CKD risk but not RKFD risk compared to conventional factors.

Conclusions:

  • A multi-marker panel offers moderate predictive improvement for renal outcomes in African Americans.
  • Specific biomarkers like adiponectin, leptin, hsCRP, and aldosterone play a role in predicting CKD and RKFD.
  • Further research may refine multi-marker panels for enhanced kidney disease risk prediction in diverse populations.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
733
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
661
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
476
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
395
Kidney Structure01:45

Kidney Structure

The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.3K
Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
365